Daniel J. O'Connor
CIK 1376847 · President and CEO · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
8
Total Filings
87
Lifetime Open-Market Net
-$845.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DMAC | Director | 0 | $5.65 | $0 | $0 | 2 | 2026-06-03 |
| Ambrx Biopharma, Inc. (AMAM) Delisted | President and CEO | 0 | $28.00 | $0 | -$491.1K | 5 | 2024-03-07 |
| SEELOS THERAPEUTICS, INC. (SEEL) Delisted | Director | 16,000 | $0.39 | $6.2K | $9.8K | 7 | 2024-01-08 |
| ZyVersa Therapeutics, Inc. (LSPRW) Delisted | Chief Executive Officer | 42,005 | $0.18 | $7.6K | $0 | 1 | 2022-03-10 |
| ONCOSEC MEDICAL Inc (ONCS) Delisted | CEO and President | 96,097 | $0.28 | $26.6K | -$48.5K | 18 | 2021-05-04 |
| Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Chief Executive Officer | 618,352 | — | — | -$68.6K | 11 | 2017-07-03 |
| Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Chief Executive Officer | 302,710 | — | — | -$247.4K | 39 | 2016-10-04 |
| IMCLONE SYSTEMS INC (IMCL) Delisted | SVP, Interim Gen. Counsel, Sec | — | — | — | $0 | 2 | 2007-02-21 |
Recent Filings · Page 5 of 9
87 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-01-03 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | +600 | $4.3K | EDGAR |
| 2016-12-01 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | +366 | $3.0K | EDGAR |
| 2016-11-07 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-11-02 | Ayala Pharmaceuticals, Inc. (ADXSW) Delisted | Mixed | −8,004 | -$66.6K | EDGAR |
| 2016-10-04 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | +304 | $3.2K | EDGAR |
| 2016-09-01 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | +282 | $3.3K | EDGAR |
| 2016-08-01 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | +571 | $4.8K | EDGAR |
| 2016-07-01 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | +1,201 | $9.7K | EDGAR |
| 2016-06-01 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | +752 | $7.0K | EDGAR |
| 2016-05-02 | Ayala Pharmaceuticals, Inc. (ADXS.W) Delisted | Mixed | −7,623 | -$57.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.